LEVELS – A Whole New Level

← LEVELS – A Whole New Level1 Oct · 1 h 25 min

#313 - What Happens When We Start Imaging Healthy People? | Dr. Daniel Durand & Mike Haney

#313 - What Happens When We Start Imaging Healthy People? | Dr. Daniel Durand & Mike Haney1 Oct1 h 25 min

<p>Most medical imaging happens after a symptom, injury, or abnormal test gives a clinician a reason to look. But what changes if imaging becomes a more routine measurement, creating a record of the body before something goes wrong?</p><p>In this episode of <em>Next Level</em>, Mike Haney talks with Dr. Daniel Durand, chief medical officer at Prenuvo, about whole-body MRI as a test case for a broader shift from episodic medicine toward longitudinal health data. Whole-body MRI is controversial, and Durand is clearly an advocate. The conversation takes the skepticism seriously, then asks a larger question: as measurement gets cheaper, more frequent, and increasingly visible to patients themselves, how should medicine decide what is worth knowing?</p><p><br></p><p><strong>Free course: Improve your metabolic health</strong></p><p>Get our free email course on how glucose, nutrition, exercise, sleep, and measurement can help you build habits that support better energy and long-term health: <a href="https://www.levels.com/partner/multimedia?utm_source=podcast&utm_medium=link&utm_content=nextlevel&partner=durand" target="_blank" rel="noopener noreferer">⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://levels.link/wnl⁠</a></p><p><br></p><p><strong>What We Cover:</strong></p><ul><li>How X-rays, CT scans, ultrasound, and MRI differ, and why radiation matters when you start thinking about repeated imaging</li><li>What whole-body MRI sees well, and where CT, colonoscopy, or blood-based approaches may still be better</li><li>The concerns around incidental findings, overdiagnosis, anxiety, and unnecessary follow-up, and Durand’s response to them</li><li>What the current cancer-detection evidence for whole-body MRI does, and does not, establish</li><li>Why having prior scans could help distinguish a stable abnormality from something genuinely new</li><li>How faster scans and AI interpretation could eventually connect imaging with genomic, proteomic, and other health data</li></ul><p><br></p><p><strong>🎙️ About the Guest:</strong></p><p>Dr. Daniel Durand is chief medical officer at Prenuvo and president of the Prenuvo Medical Group. He trained at Johns Hopkins, is board-certified in adult and pediatric radiology, and previously served as chief clinical officer and chief innovation officer at LifeBridge Health. </p><p><br></p><p><strong>📍What Dr. Daniel Durand &amp; Mike Haney discussed:</strong></p><ul><li>03:32 - Why imaging belongs in a series about continuous measurement</li><li>15:32 - Imagi